LLY
Eli Lilly and Company
Healthcare
$1,041.65
as of May 21, 2026
Latest executive report
Week 2026-W29
· updated Jul 13, 2026
Sign in to add LLY to your portfolio.
Sign inMarket cap
$958.82B
P/E (TTM)
36.0x
EPS (TTM)
$28.26
Dividend yield
0.63%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $28.32B | $5.58B | $5.39B | 74.2% | 28.0% | $5.85 |
| 2022 | $28.54B | $6.24B | $4.60B | 76.8% | 30.3% | $6.57 |
| 2023 | $34.12B | $5.24B | $-3.15B | 79.2% | 31.6% | $5.83 |
| 2024 | $45.04B | $10.59B | $414.30M | 81.3% | 38.9% | $11.76 |
| 2025 | $65.18B | $20.64B | $8.97B | 83.8% | 45.6% | $23.00 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $1,024.30 | $1,041.65 | 2.70M |
| May 20, 2026 | $1,024.99 | $1,018.87 | 3.00M |
| May 19, 2026 | $989.51 | $1,021.41 | 3.72M |
| May 18, 2026 | $1,000.61 | $988.09 | 2.02M |
| May 15, 2026 | $1,006.98 | $1,004.92 | 2.82M |
| May 14, 2026 | $1,017.49 | $1,006.70 | 1.75M |
| May 13, 2026 | $994.75 | $1,015.75 | 3.49M |
| May 12, 2026 | $974.44 | $989.87 | 3.04M |
| May 11, 2026 | $949.00 | $966.99 | 3.52M |
| May 08, 2026 | $974.07 | $948.45 | 3.56M |
| May 07, 2026 | $985.37 | $974.96 | 3.49M |
| May 06, 2026 | $991.35 | $987.05 | 3.92M |
| May 05, 2026 | $971.89 | $988.87 | 2.96M |
| May 04, 2026 | $960.00 | $967.93 | 3.70M |
| May 01, 2026 | $948.95 | $963.33 | 4.35M |
| Apr 30, 2026 | $898.78 | $934.60 | 8.24M |
| Apr 29, 2026 | $866.04 | $851.21 | 3.90M |
| Apr 28, 2026 | $871.90 | $874.00 | 2.56M |
| Apr 27, 2026 | $878.13 | $868.27 | 2.70M |
| Apr 24, 2026 | $900.01 | $883.96 | 4.46M |
| Apr 23, 2026 | $929.49 | $917.65 | 2.15M |
| Apr 22, 2026 | $906.40 | $921.48 | 2.62M |
| Apr 21, 2026 | $910.20 | $903.02 | 4.06M |
| Apr 20, 2026 | $926.90 | $919.90 | 1.93M |
Profitability & balance
- ROE (TTM)
- 101.3%
- Gross margin
- 83.5%
- Operating margin
- 45.9%
- Net margin
- 35.0%
- Debt / equity
- 1.39